June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Role of Prorenin Receptor (PRR) and NADPH Oxidase (NOX) in the Regulation of VEGF in ARPE-19 Cells under Hyperglycemic Conditions
Author Affiliations & Notes
  • Rashidul Haque
    Department of Ophthalmology, Emory University School of Medicine, Atlanta, GA
  • P Iuvone
    Department of Ophthalmology, Emory University School of Medicine, Atlanta, GA
  • Kimberly Choi
    Department of Ophthalmology, Emory University School of Medicine, Atlanta, GA
  • Daniel Park
    Department of Ophthalmology, Emory University School of Medicine, Atlanta, GA
  • Annie Farrell
    Department of Ophthalmology, Emory University School of Medicine, Atlanta, GA
  • Elizabeth Hur
    Department of Ophthalmology, Emory University School of Medicine, Atlanta, GA
  • Footnotes
    Commercial Relationships Rashidul Haque, None; P Iuvone, None; Kimberly Choi, None; Daniel Park, None; Annie Farrell, None; Elizabeth Hur, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5567. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Rashidul Haque, P Iuvone, Kimberly Choi, Daniel Park, Annie Farrell, Elizabeth Hur; Role of Prorenin Receptor (PRR) and NADPH Oxidase (NOX) in the Regulation of VEGF in ARPE-19 Cells under Hyperglycemic Conditions. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5567.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Hyperglycemia-induced increase of reactive oxygen species (ROS) is thought to be a key event in the pathogenesis of diabetic retinopathy. Diabetes-induced increase in vascular endothelial growth factor (VEGF) expression, leukocyte adhesion, and breakdown of the blood-retinal barrier are all reported to be associated with increase in ROS. Also, the stimulation of angiotensin II (Ang II), the effector peptide of renin-angiotensin system, has been reported to increase the expression of VEGF through the activation of the Ang II type 1 receptor (AT1R). The objective of this study was to investigate whether hyperglycemia in ARPE-19 cells could promote the expression of VEGF independently of Ang II through PRR, via a NOX-dependent mechanism.

Methods: ARPE-19 cells were cultured in DMEM:F12 medium with 5.5 mM glucose (normal physiological condition), supplemented with 10% FBS and penicillin/streptomycin (LONZA), at 37°C in 5% CO2 and 90% relative humidity. Hyperglycemia-mediated induction of VEGF independently of Ang II was investigated using the ACE inhibitor perindopril (10 µmol/L, Sigma), which blocks the synthesis of Ang II, and siRNA-mediated down-regulation of PRR and Nox4. To determine the signaling role of NADPH-derived superoxide (O2-) and hydrogen peroxide (H2O2) in the regulation of VEGF expression, cells were incubated with 100 U/ml of PEG-SOD (superoxide dismutase) and PEG-CAT (catalase), respectively. Cells treated with 5.5 mM glucose, scramble siRNAs, and PEG alone were used as controls. The expression of mRNAs was measured by quantitative real-time PCR (qRT-PCR).

Results: In perindopril-treated cells, hyperglycemia (33 mM glucose) significantly induced the expression of PRR (p<0.001), Nox4 (p<0.01), and VEGF (p<0.01), but not that of AT1R, Nox1, and Nox2, when compared with controls. Also, in perindopril-treated cells, PRR and Nox4 siRNAs, but not the control siRNA, significantly reduced the hyperglycemia-induced expression of VEGF (p<0.001). Both PEG-CAT and PEG-SOD, but not the PEG alone, significantly attenuated the hyperglycemia-mediated induction of VEGF (p<0.01), indicative of the involvement of NOX-derived O2- and H2O2 signaling in the regulation of VEGF.

Conclusions: Our results support the hypothesis that NOX4-derived ROS signaling is implicated in the hyperglycemia-induced increase of VEGF expression through PRR in ARPE-19 cells.

Keywords: 499 diabetic retinopathy • 701 retinal pigment epithelium • 748 vascular endothelial growth factor  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×